Comparison
While Ipamorelin is investigated for producing moderate, physiologic-like GH pulses useful for studying anabolic, body-composition, and recovery effects with a relatively clean endocrine side-effect profile compared with earlier GHRPs16, Semaglutide is approved for type 2 diabetes and chronic weight management, significantly lowering HbA1c and body weight by modulating incretin pathways232480.
While Ipamorelin works as a third-generation pentapeptide growth hormone secretagogue that selectively agonizes the ghrelin (GHSR-1a) receptor to trigger controlled, GH-specific pituitary release with minimal effects on cortisol or prolactin16269596, Semaglutide is a modified GLP-1(7–37) analog with three key changes—Ala8→Aib, Lys26 acylated with a C18 fatty diacid, and Lys34→Arg—resulting in a long-acting GLP-1 receptor agonist that enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite23647480.
Ipamorelin is 5 amino acids long, whereas Semaglutide is longer as it has a length of 31 amino acids. Ipamorelin is made up of a sequence of Aib, Histidine, D-2-Nal, Phenylalanine, Lysine. Semaglutide is made up of a sequence of sequence data not available in the current dataset.
Ipamorelin
GHSR
Semaglutide
GCG